Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 29, 2017

DrugPatentWatch Database Preview

TOBRAMYCIN SULFATE Drug Profile

« Back to Dashboard

Which patents cover Tobramycin Sulfate, and what generic alternatives are available?

Tobramycin Sulfate is a drug marketed by Teva Pharms Usa, Mylan Labs Ltd, Hospira, West-ward Pharms Int, X Gen Pharms, Igi Labs Inc, Apothecon, Fresenius Kabi Usa, Watson Labs Inc, Claris, Akorn, and Xellia Pharms Aps. and is included in twenty-seven NDAs.

The generic ingredient in TOBRAMYCIN SULFATE is tobramycin sulfate. There are eighteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the tobramycin sulfate profile page.

Summary for Tradename: TOBRAMYCIN SULFATE

Patents:0
Applicants:12
NDAs:27
Suppliers / Packagers: see list9
Bulk Api Vendors: see list66
Clinical Trials: see list299
Patent Applications: see list6,339
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TOBRAMYCIN SULFATE at DailyMed

Pharmacology for Tradename: TOBRAMYCIN SULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira
TOBRAMYCIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
tobramycin sulfate
INJECTABLE;INJECTION063081-001Jul 31, 1990RXNoYes► Subscribe► Subscribe
Hospira
TOBRAMYCIN SULFATE (PHARMACY BULK)
tobramycin sulfate
INJECTABLE;INJECTION063116-001May 18, 1992DISCNNoNo► Subscribe► Subscribe
Fresenius Kabi Usa
TOBRAMYCIN SULFATE (PHARMACY BULK)
tobramycin sulfate
INJECTABLE;INJECTION065120-001Nov 29, 2002RXNoYes► Subscribe► Subscribe
Teva Pharms Usa
TOBRAMYCIN SULFATE
tobramycin sulfate
INJECTABLE;INJECTION063100-001Jan 30, 1992APRXNoNo► Subscribe► Subscribe
West-ward Pharms Int
TOBRAMYCIN SULFATE
tobramycin sulfate
INJECTABLE;INJECTION063127-001Nov 27, 1991DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Find generic sources and suppliers
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot